Assessment of Medication Adherence in Patients With Schizophrenia: The Achilles Heel of Adherence Research

Measuring medication adherence in patients with schizophrenia is difficult and lacks a gold standard. Consequently, a great number of different methods and instruments have been proposed. Although it has been assumed that they all measure medication adherence, this study demonstrates that instruments differ significantly. Using data from an international multisite study (N = 329), we found that 3 questionnaires, designed to measure medication adherence and typical for instruments used in studies in patients with schizophrenia, do not agree in labeling patients as nonadherent. Further, they seem not to measure the same trait, are related to different established risk factors of nonadherence, and are only weakly related to these established risk factors of nonadherence. If these results are representative of the validity of other measures used in adherence research, this may have serious consequences for the interpretation of, and explanations for discrepancies found in the literature. Researchers should be aware of this problem and continue to combine objective and subjective methods in the hope of increasing the reliability and validity of measures of adherence.

[1]  A. David,et al.  Adherence therapy for people with schizophrenia , 2006, British Journal of Psychiatry.

[2]  Jacqueline L Johnson,et al.  Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode , 2006, Schizophrenia Research.

[3]  M. Byerly,et al.  Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics , 2006, Schizophrenia Research.

[4]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[5]  Alexander L. Miller,et al.  Defining and assessing adherence to oral antipsychotics: a review of the literature. , 2005, Schizophrenia bulletin.

[6]  G. Thornicroft,et al.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. , 2005, Schizophrenia bulletin.

[7]  Mary T. Roth,et al.  Self-reported medication use in community-residing older adults: A pilot study. , 2005, The American journal of geriatric pharmacotherapy.

[8]  M. Ruggeri,et al.  Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries , 2005, Schizophrenia Research.

[9]  S. Marder,et al.  Subjective experiences on antipsychotic medications: synthesis and conclusions , 2005, Acta psychiatrica Scandinavica. Supplementum.

[10]  M. Lambert,et al.  Subjective well‐being under neuroleptic treatment and its relevance for compliance , 2005, Acta psychiatrica Scandinavica. Supplementum.

[11]  S-71. Symposium: The QUATRO study — an European randomised controlled trial of compliance therapy , 2005, European Psychiatry.

[12]  C. Bova,et al.  Use of Electronic Monitoring Devices to Measure Antiretroviral Adherence: Practical Considerations , 2005, AIDS and Behavior.

[13]  A. Rush,et al.  A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia , 2005, Psychiatry Research.

[14]  Y. Ahn,et al.  Liverpool University Neuroleptic Side‐Effect Rating Scale (LUNSERS) as a subjective measure of drug‐induced parkinsonism and akathisia , 2005, Human psychopharmacology.

[15]  Adrian R Levy,et al.  Self-Reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications , 2004, The Annals of pharmacotherapy.

[16]  H. Tobi,et al.  Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data , 2004, Pharmacoepidemiology and drug safety.

[17]  S. Hutton,et al.  Clinical correlates of early medication adherence: West London first episode schizophrenia study , 2003, Acta psychiatrica Scandinavica.

[18]  M. Tansella,et al.  How often do patients with psychosis fail to adhere to treatment programmes? A systematic review , 2003, Psychological Medicine.

[19]  L. Ereshefsky,et al.  Comparative assessment of antipsychotic adherence by concentration monitoring, pill count and self-report , 2003, Schizophrenia Research.

[20]  Diana O Perkins,et al.  Predictors of noncompliance in patients with schizophrenia. , 2002, The Journal of clinical psychiatry.

[21]  Christian R. Dolder,et al.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.

[22]  J. Endicott,et al.  The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study , 2002, European Neuropsychopharmacology.

[23]  B. Happell,et al.  EXPLORING THE COMPLEXITY OF COMPLIANCE IN SCHIZOPHRENIA , 2002, Issues in mental health nursing.

[24]  J. Cramer,et al.  Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. , 2001, Journal of psychiatry & neuroscience : JPN.

[25]  W. Fleischhacker,et al.  Compliance with antipsychotic treatment , 2000, Acta psychiatrica Scandinavica. Supplementum.

[26]  R C Peveler,et al.  Compliance with tricyclic antidepressants: the value of four different methods of assessment. , 2000, British journal of clinical pharmacology.

[27]  M. Knapp,et al.  Client Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international research , 2000, British Journal of Psychiatry.

[28]  J. Vázquez-Barquero,et al.  Caregiving in schizophrenia: development, internal consistency and reliability of the Involvement Evaluation Questionnaire – European Version , 2000, British Journal of Psychiatry.

[29]  A. Sergejew,et al.  Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses , 2000, Schizophrenia Research.

[30]  Jan Scott,et al.  Predicting medication adherence in severe mental disorders , 2000, Acta psychiatrica Scandinavica.

[31]  W. Haefeli,et al.  Overconsumption detected by electronic drug monitoring requires subtle interpretation , 2000, Clinical pharmacology and therapeutics.

[32]  M. Nichol,et al.  A Critical Evaluation of the Methodology of the Literature on Medication Compliance , 1999, The Annals of pharmacotherapy.

[33]  R. Rosenheck,et al.  Compliance with medication regimens for mental and physical disorders. , 1998, Psychiatric services.

[34]  José L. Ayuso-Gutiérrez,et al.  Factors influencing relapse in the long-term course of schizophrenia , 1997, Schizophrenia Research.

[35]  A. David,et al.  Psychological Predictors of Insight and Compliance in Psychotic Patients , 1996, British Journal of Psychiatry.

[36]  R. Bentall,et al.  A Self-Rating Scale for Measuring Neuroleptic Side-Effects , 1995, British Journal of Psychiatry.

[37]  M. Coffey,et al.  A Brief Mental Health Outcome Scale , 1995, British Journal of Psychiatry.

[38]  S. G. Adams,et al.  Predicting Medication Compliance in a Psychotic Population , 1993, The Journal of nervous and mental disease.

[39]  Jean Addington,et al.  Reliability and validity of a depression rating scale for schizophrenics , 1991, Schizophrenia Research.

[40]  T. Brugha,et al.  SCAN. Schedules for Clinical Assessment in Neuropsychiatry. , 1990, Archives of general psychiatry.

[41]  A. David,et al.  Insight and Psychosis , 1990, British Journal of Psychiatry.

[42]  J L Young,et al.  Medication noncompliance in schizophrenia: codification and update. , 1986, The Bulletin of the American Academy of Psychiatry and the Law.

[43]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[44]  D. Chan.  Medication compliance in a Chinese psychiatric out-patient setting. , 1984, The British journal of medical psychology.

[45]  T. Hogan,et al.  A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity , 1983, Psychological Medicine.

[46]  M. Koeter,et al.  Family caregiving in schizophrenia: domains and distress. , 1998, Schizophrenia bulletin.

[47]  W S Fenton,et al.  Determinants of medication compliance in schizophrenia: empirical and clinical findings. , 1997, Schizophrenia bulletin.

[48]  Organización Mundial de la Salud.  Guidelines for ATC classification and DDD assignment , 1996 .

[49]  J. Kane.  Problems of compliance in the outpatient treatment of schizophrenia. , 1983, The Journal of clinical psychiatry.